Wounds and Injuries

0
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
2 programs
International Kink Health StudyN/A1 trial
Monitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult ContextsN/A1 trial
Active Trials
NCT05318053Completed917Est. Mar 2024
NCT01779011Completed305Est. May 2012
Zoll
ZollCA - San Jose
1 program
Closed Loop Control VentilationN/A1 trial
Active Trials
NCT02810080Completed210Est. Dec 2020
Crescent Biopharma
1 program
InfectedN/A1 trial
Active Trials
NCT03463720CompletedEst. May 2012
Bayer
BayerLEVERKUSEN, Germany
1 program
Plasmalyte AN/A1 trial
Active Trials
NCT01270854Completed46Est. Apr 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsInternational Kink Health Study
ZollClosed Loop Control Ventilation
BayerPlasmalyte A
Alliance PharmaceuticalsMonitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts
Crescent BiopharmaInfected

Clinical Trials (5)

Total enrollment: 1,478 patients across 5 trials

NCT05318053Alliance PharmaceuticalsInternational Kink Health Study

International Kink Health Study

Start: Jun 2022Est. completion: Mar 2024917 patients
N/ACompleted
NCT02810080ZollClosed Loop Control Ventilation

FiO2 Closed Loop Control Ventilation

Start: Dec 2016Est. completion: Dec 2020210 patients
N/ACompleted
NCT01270854BayerPlasmalyte A

Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients

Start: Feb 2011Est. completion: Apr 201246 patients
N/ACompleted
NCT01779011Alliance PharmaceuticalsMonitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts

Monitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts

Start: Jan 2011Est. completion: May 2012305 patients
N/ACompleted

Outcome for Patients With War-Associated Extremity Wound Infection

Start: Sep 2010Est. completion: May 2012
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space